Breaking News Instant updates and real-time market news.

SNSS

Sunesis

$2.45

0.06 (2.51%)

16:36
08/07/18
08/07
16:36
08/07/18
16:36

Sunesis reports Q2 EPS (20c), consensus (24c)

Reports Q2 revenue $0.0, consensus $280K."During the second quarter, we continued to focus on advancing our Phase 1b/2 trial evaluating our lead program, the non-covalent BTK inhibitor vecabrutinib, to help patients who have developed resistance to covalent BTK inhibitors such as ibrutinib," said Dayton Misfeldt, Interim Chief Executive Officer of Sunesis. "Specifically, we have added clinical sites, including the recent additions of Memorial Sloan Kettering Cancer Center and Moffitt Cancer Center, and strengthened our development team. We also entered into a financing facility with Aspire Capital to provide us with another flexible financing tool to support our development programs. We expect to present an update on our ongoing vecabrutinib trial at the annual American Society of Hematology meeting."

  • 07

    Aug

SNSS Sunesis
$2.45

0.06 (2.51%)

12/11/17
WELS
12/11/17
UPGRADE
Target $8
WELS
Outperform
Sunesis upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Jim Birchenough upgraded Sunesis Pharmaceuticals to Outperform following a review of updated data for novel BTK inhibitor vecabrutinib at the American Society of Hematology meeting. Expert feedback at the meeting suggests vecabrutinib could become treatment of choice for Imbruvica resistance and ultimately a preferred choice over Imbruvica as a frontline treatment in a $3B-plus BTK inhibitor market, Birchenough tells investors in a research note. The analyst expects positive vecabrutinib data despite recent management departures and upped his price target for Sunesis shares to $8 from $2.
12/05/17
CANT
12/05/17
NO CHANGE
Target $3
CANT
Neutral
Sunesis clinical picture unchanged with CEO leaving, says Cantor Fitzgerald
Cantor Fitzgerald analyst Mara Goldstein believes shares of Sunesis Pharmaceuticals could face pressure on the resignation of President and CEO Dan Swisher. The loss, however, is not an indictment of the clinical potential of SNS-062, Goldstein tells investors in a research note. However, the analyst believes the resignation makes it harder for investors to maintain focus on the company without a CEO at the helm, particularly as interim data are not expected until mid-2018. She keeps a Neutral rating on Sunesis with a $3 price target.
12/05/17
WELS
12/05/17
DOWNGRADE
Target $2
WELS
Market Perform
Sunesis downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Jim Birchenough downgraded Sunesis Pharmaceuticals to Market Perform following the resignation of the company's CEO Daniel Swisher. While the executive is pursuing an attractive opportunity at a larger biopharmaceutical company, the move highlights the early stage nature of Sunesis' pipeline, extended timelines for development and potential risk in realizing the potential for lead BTK inhibitor SNS062, Birchenough tells investors in a research note. The analyst cut his price target for the shares to $2 from $5.
11/21/17
11/21/17
INITIATION
Target $7

Outperform
Oppenheimer says Sunesis has defined opportunity, initiates with Outperform
As previously reported, Oppenheimer analyst Hartaj Singh started Sunesis (SNSS) with an Outperform rating and $7 price target. While AbbVie's (ABBV) ibrutinib has demonstrated a robust risk/benefit profile across many tumor types, it is becoming apparent that about 10% or more of leukemia and lymphoma patients have a mutation that leads to relapse on ibrutinib, he contends. The analyst believes Sunesis' reversible and potent BTK inhibitor SNS-062 has the ability to address this patient population, both upon relapse following ibrutinib or directly through a biomarker-driven approach.

TODAY'S FREE FLY STORIES

OESX

Orion Energy

$0.80

-0.0501 (-5.89%)

12:44
11/13/18
11/13
12:44
11/13/18
12:44
Recommendations
Orion Energy analyst commentary  »

Orion Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SBUX

Starbucks

$68.05

0.14 (0.21%)

12:41
11/13/18
11/13
12:41
11/13/18
12:41
Periodicals
Starbucks lays off 5%, or 350, corporate employees, Seattle Times reports »

As part of its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MET

MetLife

$46.01

1.29 (2.88%)

12:40
11/13/18
11/13
12:40
11/13/18
12:40
Options
8.2K Metlife Jan 47.5 - 50 call spreads bought for 82c »

8.2K Metlife Jan 47.5 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CKPT

Checkpoint Therapeutics

$2.37

0.19 (8.72%)

12:38
11/13/18
11/13
12:38
11/13/18
12:38
Hot Stocks
Checkpoint Therapeutics director Lindsay Rosenwald buys 100K shares of stock »

Checkpoint Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEAR

Turtle Beach

$15.81

0.56 (3.67%)

12:35
11/13/18
11/13
12:35
11/13/18
12:35
Options
Turtle Beach put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

KORS

Michael Kors

$49.26

1.51 (3.16%)

12:34
11/13/18
11/13
12:34
11/13/18
12:34
Hot Stocks
Michael Kors CEO sees double digit revenue growth in 2020 »

Michael Kors Chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SBUX

Starbucks

$68.02

0.11 (0.16%)

12:32
11/13/18
11/13
12:32
11/13/18
12:32
Periodicals
Starbucks to lay off 5% of corporate workforce, Dow Jones says »

The layoffs, which total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

VOYA

Voya Financial

$46.22

1.635 (3.67%)

12:29
11/13/18
11/13
12:29
11/13/18
12:29
Hot Stocks
Breaking Hot Stocks news story on Voya Financial »

Voya Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

NIO

NIO Inc.

$6.77

0.12 (1.80%)

12:25
11/13/18
11/13
12:25
11/13/18
12:25
Options
NIO Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
11/13/18
11/13
12:25
11/13/18
12:25
Conference/Events
William Blair specialty finance analyst holds a group luncheon »

Specialty Finance Analyst…

DVMT

Dell Technologies

$103.00

4.58 (4.65%)

, VMW

VMware

$151.32

3.16 (2.13%)

12:24
11/13/18
11/13
12:24
11/13/18
12:24
Periodicals
Dell considering raising bid for DVMT tracking stock, Reuters says »

Dell Technologies (DVMT)…

DVMT

Dell Technologies

$103.00

4.58 (4.65%)

VMW

VMware

$151.32

3.16 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 11

    Dec

AKRX

Akorn

$6.74

0.02 (0.30%)

, TEVA

Teva

$23.78

0.09 (0.38%)

12:18
11/13/18
11/13
12:18
11/13/18
12:18
Periodicals
Court rules Allergan's patents on Restasis are invalid, Bloomberg reports »

The U.S. Court of Appeals…

AKRX

Akorn

$6.74

0.02 (0.30%)

TEVA

Teva

$23.78

0.09 (0.38%)

AGN

Allergan

$163.97

0.15 (0.09%)

MYL

Mylan

$36.19

0.25 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 15

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/13/18
11/13
12:17
11/13/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$274.51

1.92 (0.70%)

, SPX

S&P 500

$0.00

(0.00%)

12:16
11/13/18
11/13
12:16
11/13/18
12:16
Periodicals
John Kelly may soon depart Trump administration, NBC News reports »

Chief of Staff John Kelly…

SPY

SPDR S&P 500 ETF Trust

$274.51

1.92 (0.70%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/13/18
11/13
12:16
11/13/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$47.77

-2.87 (-5.67%)

12:15
11/13/18
11/13
12:15
11/13/18
12:15
Options
Etsy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$274.18

1.59 (0.58%)

12:13
11/13/18
11/13
12:13
11/13/18
12:13
General news
Trump says New York Times story on North Korea missile bases 'inaccurate' »

President Donald Trump…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$274.18

1.59 (0.58%)

NYT

New York Times

$26.21

-0.135 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUM

Summit Materials

$13.58

0.33 (2.49%)

12:11
11/13/18
11/13
12:11
11/13/18
12:11
Hot Stocks
Breaking Hot Stocks news story on Summit Materials »

Southeastern Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,659.40

22.7 (1.39%)

, HD

Home Depot

$176.79

-2.72 (-1.52%)

12:08
11/13/18
11/13
12:08
11/13/18
12:08
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks have endured a…

AMZN

Amazon.com

$1,659.40

22.7 (1.39%)

HD

Home Depot

$176.79

-2.72 (-1.52%)

AAPL

Apple

$195.05

0.895 (0.46%)

QRVO

Qorvo

$63.65

-0.15 (-0.24%)

GE

General Electric

$8.53

0.55 (6.89%)

BHGE

Baker Hughes

$24.40

0.77 (3.26%)

LITE

Lumentum

$39.86

2.355 (6.28%)

JCI

Johnson Controls

$35.65

1.47 (4.30%)

BBU

Brookfield Business Partners

$37.95

1.1 (2.99%)

NVDA

Nvidia

$202.02

12.65 (6.68%)

AAP

Advance Auto Parts

$182.72

15.78 (9.45%)

JKHY

Jack Henry

$139.74

-1.57 (-1.11%)

TSN

Tyson Foods

$58.10

-3.41 (-5.54%)

EPC

Edgewell Personal Care

$43.11

-3.13 (-6.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 26

    Nov

  • 28

    Nov

  • 29

    Nov

  • 04

    Dec

  • 10

    Dec

  • 03

    Mar

  • 15

    Nov

AMZN

Amazon.com

$1,659.46

22.76 (1.39%)

12:08
11/13/18
11/13
12:08
11/13/18
12:08
Recommendations
Amazon.com analyst commentary  »

Amazon.com HQ2 locations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

UPS

UPS

$110.25

2.51 (2.33%)

12:06
11/13/18
11/13
12:06
11/13/18
12:06
Hot Stocks
UPS adds 14 new countries served by UPS Worldwide Express »

UPS announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SBGI

Sinclair Broadcast

$31.54

0.26 (0.83%)

, TRCO

Tribune Media

$39.10

-0.255 (-0.65%)

12:05
11/13/18
11/13
12:05
11/13/18
12:05
Periodicals
Sinclair, Tribune resolve DOJ case over ad sales, Bloomberg says »

Sinclair Broadcast…

SBGI

Sinclair Broadcast

$31.54

0.26 (0.83%)

TRCO

Tribune Media

$39.10

-0.255 (-0.65%)

MDP

Meredith

$56.98

-0.06 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 15

    Nov

SWN

Southwestern Energy

$6.04

0.24 (4.14%)

12:05
11/13/18
11/13
12:05
11/13/18
12:05
Options
Southwestern Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ZEN

Zendesk

$53.52

0.32 (0.60%)

, AMZN

Amazon.com

$1,658.41

21.71 (1.33%)

12:03
11/13/18
11/13
12:03
11/13/18
12:03
Hot Stocks
Zendesk launches Sunshine, 'an open and flexible CRM platform' »

Zendesk (ZEN) launched…

ZEN

Zendesk

$53.52

0.32 (0.60%)

AMZN

Amazon.com

$1,658.41

21.71 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

  • 06

    Dec

  • 06

    Dec

  • 12

    Dec

  • 13

    Dec

JBLU

JetBlue

$18.24

0.27 (1.50%)

12:02
11/13/18
11/13
12:02
11/13/18
12:02
Hot Stocks
JetBlue appoints Brandon Nelson general counsel, corporate secretary »

JetBlue announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.